Mutual Of America Capital Management LLC Allakos Inc. Transaction History

Mutual Of America Capital Management LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 03, 2022	SELL	$8.55 - $111.89 $199,505 - $2.61 Million	-23,334 Closed	0 $0
Q3 2021 Nov 10, 2021	SELL	$76.53 - $110.43 $25,714 - $37,104	-336 Reduced 1.42%	23,334 $2.47 Million
Q2 2021 Aug 06, 2021	SELL	$85.37 - $114.1 $86,906 - $116,153	-1,018 Reduced 4.12%	23,670 $2.02 Million
Q1 2021 May 13, 2021	BUY	$109.73 - $153.66 $324,581 - $454,526	2,958 Added 13.61%	24,688 $2.83 Million
Q4 2020 Feb 12, 2021	BUY	$79.58 - $152.45 $1.73 Million - $3.31 Million	21,730 New	21,730 $3.04 Million

64.7M

47.1K

Ticker ALLK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 84,726,096
Market Cap $91.5M
Description
Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...

Get notified when there are updates to the investment portfolio of Mutual Of America Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Mutual Of America Capital Management LLC with notifications on news.